p, a, button, span, label, blockquote, th, tr, caption, h1, h2, h3, h4, h5, h6 { opacity: 1; } JavaScript is currently disabled. Please enable JavaScript for an optimal experience.

Home Page

Christopher Lewis Reading, PhD

Donate Now

Christopher Lewis Reading, PhD

Chief Scientific Officer at Harbor Therapeutics, Inc.

Location: San Diego, CA United States

Associated Grants

Anti-parkinsonian and Anti-dyskinetic Efficacy of HE3286 in a Model of Parkinson’s Disease

2012

Read More

Animations

Christopher Lewis Reading, PhD

Chief Scientific Officer at Harbor Therapeutics, Inc.

Location: San Diego, CA United States

Associated Grants

Anti-parkinsonian and Anti-dyskinetic Efficacy of HE3286 in a Model of Parkinson’s Disease